-+ 0.00%
-+ 0.00%
-+ 0.00%

Evogene Q3 EPS $(0.31) Beats $(0.41) Estimate, Sales $312.000K Miss $650.000K Estimate

Benzinga·11/20/2025 12:30:26
Listen to the news
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.41) by 24.39 percent. This is a 76.34 percent increase over losses of $(1.31) per share from the same period last year. The company reported quarterly sales of $312.000 thousand which missed the analyst consensus estimate of $650.000 thousand by 52.00 percent. This is a 82.63 percent decrease over sales of $1.796 million the same period last year.